The subsidiary of pharma major Glenmark Pharmaceuticals, Glenmark Life Sciences, is expected to raise around Rs 1,500 crore through its initial public offering (IPO). The offer will open on July 27 …
( read original story …)
The Taiwan NEWS
The subsidiary of pharma major Glenmark Pharmaceuticals, Glenmark Life Sciences, is expected to raise around Rs 1,500 crore through its initial public offering (IPO). The offer will open on July 27 …
( read original story …)